L-cysteine administration prevents liver fibrosis by suppressing hepatic stellate cell proliferation and activation

被引:22
|
作者
Horie, T
Sakaida, I [1 ]
Yokoya, F
Nakajo, M
Sonaka, I
Okita, K
机构
[1] Yamaguchi Univ, Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi 7558505, Japan
[2] Ajinomoto Co Inc, Pharmaceut Res Labs, Kawasaki Ku, Kawasaki, Kanagawa 2108681, Japan
关键词
L-cysteine; liver fibrosis; dimethylnitrosamine; hepatic stellate cell;
D O I
10.1016/S0006-291X(03)00691-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent studies showed that the function of some amino acids is not only nutritional but also pharmacological. However, the effects of amino acids on liver fibrosis and hepatic stellate cell (HSC) remain unclear. In this research, as a result of screening of amino acids using liver fibrosis induced by DMN administration, L-cysteine was selected as a suppressor of liver fibrosis. Furthermore, the number of activated HSCs, which increased in the fibrotic liver after DMN administration, was decreased in L-cysteine-fed rats. Treatment of freshly isolated HSCs With L-cysteine resulted in inhibition of the increase in smooth muscle alpha-actin (alphaSMA) expression by HSCs and BrdU incorporation into the activated HSCs. These findings suggest that L-cysteine is effective against liver fibrosis. The mechanism of inhibition of fibrosis in the liver is surmized to be direct inhibition of activated HSC proliferation and HSC transformation by L-cysteine. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:94 / 100
页数:7
相关论文
共 50 条
  • [41] Inhibitory Effect of Sestrin 2 on Hepatic Stellate Cell Activation and Liver Fibrosis
    Yang, Ji Hye
    Kim, Kyu Min
    Cho, Sam Seok
    Shin, Sang Mi
    Ka, Sun O.
    Na, Chang-Su
    Park, Byung Hyun
    Jegal, Kyung Hwan
    Kim, Jae Kwang
    Ku, Sae Kwang
    Lee, Hee-Jeong
    Park, Sang-Gon
    Cho, Il Je
    Ki, Sung Hwan
    ANTIOXIDANTS & REDOX SIGNALING, 2019, 31 (03) : 243 - 259
  • [42] Human antigen R contributes to hepatic stellate cell activation and liver fibrosis
    Woodhoo, Ashwin
    Iruarrizaga-Lejarreta, Marta
    Beraza, Naiara
    Garcia-Rodriguez, Juan L.
    Embade, Nieves
    Fernandez-Ramos, David
    Martinez-Lopez, Nuria
    Gutierrez-De Juan, Virginia
    Arteta, Beatriz
    Caballeria, Juan
    Lu, Shelly C.
    Mato, Jose M.
    Varela-Rey, Marta
    Martinez-Chantar, Maria L.
    HEPATOLOGY, 2012, 56 (05) : 1870 - 1882
  • [43] Inhibition of Hepatic Stellate Cell Activation and Liver Fibrosis by Expression of Cytoglobin In Vivo
    Xu, Ruian
    Harrison, Phillip
    Li, Xinyan
    Chen, Miao
    Li, Hua
    Cheung, Pik-to
    Xiao, Weidong
    Farzaneh, Farzin
    MOLECULAR THERAPY, 2006, 13 : S171 - S172
  • [44] Betulinic acid prevents liver fibrosis by binding Lck and suppressing Lck in HSC activation and proliferation
    Zhao, Huizi
    Wu, Lin
    Zhang, Yuan
    Feng, Shiqi
    Ding, Yuhao
    Ding, Xin
    Feng, Rui
    Li, Jun
    Ma, Taotao
    JOURNAL OF ETHNOPHARMACOLOGY, 2022, 296
  • [45] Eupatilin Ameliorates Hepatic Fibrosis and Hepatic Stellate Cell Activation by Suppressing β-catenin/PAI-1 Pathway
    Hu, Jinyuan
    Liu, Yuanyuan
    Pan, Zheng
    Huang, Xuekuan
    Wang, Jianwei
    Cao, Wenfu
    Chen, Zhiwei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [46] HUMAN TONSIL MESENCHYMAL STEM CELL-DERIVED EXOSOMES ALLEVIATE LIVER FIBROSIS BY SUPPRESSING ACTIVATION OF HEPATIC STELLATE CELLS
    Shin, Yongbo
    Kim, Jieun
    Wang, Sihyung
    Lee, Chanbin
    Jung, Youngmi
    HEPATOLOGY, 2019, 70 : 1107A - 1107A
  • [47] Decellularized hepatic extracellular matrix hydrogel attenuates hepatic stellate cell activation and liver fibrosis
    Hussein, Kamal H.
    Park, Kyung-Mee
    Yu, Lina
    Kwak, Ho-Hyun
    Woo, Heung-Myong
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2020, 116
  • [48] Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
    Schon, Hans-Theo
    Bartneck, Matthias
    Borkham-Kamphorst, Erwan
    Natterman, Jacob
    Lammers, Twan
    Tacke, Frank
    Weiskirchen, Ralf
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [49] Diisopropylamine dichloroacetate alleviates liver fibrosis through inhibiting activation and proliferation of hepatic stellate cells
    Yan, Chen
    Wu, Xing-Yu
    Luo, Ou-Yang
    Su, Lei
    Ding, Yi-Tao
    Jiang, Yong
    Yu, De-Cai
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (04): : 3440 - 3448
  • [50] Smad7 prevents activation of hepatic stellate cells and experimentally induced fibrosis in rat liver
    Dooley, S
    Delvoux, B
    Hamzavi, J
    Breitkopf, K
    Goldberg, G
    Denecke, B
    Jahnen-Dechent, W
    Lorenzen, J
    ten Dijke, P
    Gressner, AM
    HEPATOLOGY, 2002, 36 (04) : 224A - 224A